Tweaked psychedelic drug could treat addiction, depression
A modified ibogaine molecule could be a safer and more accessible treatment for addiction and depression than the psychedelic drug in its natural state.
FDA: Smokeless cigarettes produce less harmful chemicals
FDA clears Philip Morris to market its smokeless cigarettes as modified risk tobacco products, which could benefit smokers battling a nicotine addiction.
Addict-turned-neuroscientist on addiction and the brain
In our interview with neuroscientist Judith Grisel, she discusses the state of research on addiction and the brain, as well as society’s view of addicts.
This week in ideas: Fighting addiction with implants, using VR to educate, Amazon Prime gets primer
An arm implant to treat opioid addiction, teaching hair stylists with VR, and a potential Amazon Prime game changer.